UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$463M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$360M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$345M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$265M |
| 5 |
ConocoPhillips
COP
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$293M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$239M |
| 5 |
UnitedHealth
UNH
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.86% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTVE
2426
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $321K | ﹤0.01% |
+36,726
| New | +$381K |
|
2427
Veritone
VERI
$122M
| $320K | ﹤0.01% |
56,775
+18,357
| +48% | +$129K |
|
2428
Nuvation Bio
NUVB
$2.32B
| $319K | ﹤0.01% |
142,374
-16,838
| -11% | -$48.1K |
|
2429
AMC Global Media
AMCX
$489M
| $319K | ﹤0.01% |
15,706
-9,768
| -38% | -$269K |
|
2430
Sana Biotechnology
SANA
$980M
| $316K | ﹤0.01% |
52,618
-19,982
| -28% | -$144K |
|
2431
i3 Verticals
IIIV
$342M
| $315K | ﹤0.01% |
15,712
| – | – |
|
2432
Cimpress
CMPR
$2.31B
| $315K | ﹤0.01% |
12,853
-9,156
| -42% | -$313K |
|
2433
Ambev
ABEV
$46.4B
| $311K | ﹤0.01% |
+109,800
| New | +$311K |
|
2434
Atara Biotherapeutics
ATRA
$76.1M
| $308K | ﹤0.01% |
3,261
| – | – |
|
|
TUP
2435
DELISTED
Tupperware Brands Corporation
TUP
| $307K | ﹤0.01% |
46,830
-11,493
| -20% | -$103K |
|
2436
Chunghwa Telecom
CHT
$33B
| $306K | ﹤0.01% |
+8,615
| New | +$343K |
|
2437
Waterstone Financial
WSBF
$375M
| $305K | ﹤0.01% |
18,856
| – | – |
|
2438
Camden National
CAC
$976M
| $301K | ﹤0.01% |
7,055
+2,277
| +48% | +$103K |
|
2439
Independent Bank Corp
IBCP
$844M
| $299K | ﹤0.01% |
15,636
+3,836
| +33% | +$77.8K |
|
|
EBIX
2440
DELISTED
Ebix Inc
EBIX
| $297K | ﹤0.01% |
15,671
-6,825
| -30% | -$150K |
|
|
TPC
2441
Tutor Perini Cor
TPC
$5.21B
| $297K | ﹤0.01% |
53,744
-6,006
| -10% | -$45.6K |
|
2442
Angi Inc
ANGI
$196M
| $296K | ﹤0.01% |
10,051
+2,304
| +30% | +$101K |
|
|
AVDX
2443
DELISTED
AvidXchange
AVDX
| $296K | ﹤0.01% |
35,200
-15,500
| -31% | -$120K |
|
|
SOVO
2444
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $295K | ﹤0.01% |
20,700
| – | – |
|
2445
Haverty Furniture Companies
HVT
$454M
| $295K | ﹤0.01% |
11,837
-1,993
| -14% | -$54K |
|
2446
1st Source
SRCE
$2.12B
| $291K | ﹤0.01% |
6,289
| – | – |
|
2447
Inovio Pharmaceuticals
INO
$69M
| $290K | ﹤0.01% |
13,999
-3,752
| -21% | -$96.1K |
|
|
RAPT
2448
DELISTED
RAPT Therapeutics
RAPT
| $288K | ﹤0.01% |
1,498
| – | – |
|
|
BBIG
2449
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| $287K | ﹤0.01% |
15,425
+11,385
| +282% | +$227K |
|
2450
Evolus
EOLS
$501M
| $286K | ﹤0.01% |
35,510
-8,139
| -19% | -$86.3K |
|
Similar funds
UBS AM's Q3 2022 Portfolio in Review
As of Q3 2022, UBS AM held 2,816 positions worth $178B, down 6.6% from $191B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM's Q3 2022 filing shows 65 new, 702 increased, 1,679 reduced and 77 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M. The largest sale was Apple, an estimated $2.03B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q3 2022 buy was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M.
- UBS AM added most to Accenture in Q3 2022, an estimated $463M increase.
- UBS AM's biggest Q3 2022 reduction was Apple, cutting an estimated $2.03B.
- UBS AM fully exited Vanguard Russell 1000 ETF in Q3 2022, selling an estimated $93.3M.
- UBS AM's ten largest holdings make up 21% of its $178B portfolio in Q3 2022.
- UBS AM opened 65 new positions and closed 77 in Q3 2022.
- UBS AM's portfolio value fell 6.6% quarter-over-quarter to $178B.
Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.